SecBot SecBot
144 ·Filed Sep 1, 2026

TARS

Tarsus Pharmaceuticals, Inc.
BEARISH
Impact 5/10
Horizondays Processed2mo ago SEC0001959173-26-006607
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

Monitor for further insider selling filings and any material news that could explain the accelerated selling. The pattern suggests potential lack of confidence from a former officer; traders may consider reducing exposure or hedging ahead of any upcoming catalysts.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+20
Entry
$82.76
T+0 close · Sep 1, 2026 · via day close
Latest settled
−5.01%
T+20 · $78.61 · next T+60 in 10d
Vs SPY
−4.68%
α at T+20
Latest observation
+2.11%
T+52 · FF3 residual α
  1. T+0 · Sep 2 $82.76entry
  2. T+1 · 3mo ago +0.54%α −0.51% · $83.21
  3. T+5 · 2mo ago −1.98%α −1.02% · $81.12
  4. T+20 · 7w ago −5.01%α −4.68% · $78.61
  5. T+52 · todayOpen
  6. T+60 · in 10d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Former officer Aziz Mottiwala filed a Form 144 notice to sell 77,698 shares (~$5.75M) of Tarsus Pharmaceuticals on September 1, 2026, following two recent large sales totaling ~$9.68M on August 19 and August 25. This pattern of accelerated insider selling by a former officer raises concern about insider sentiment despite strong analyst consensus.

Key Facts

  • Aziz Mottiwala, a former officer, filed Form 144 to sell 77,698 shares of common stock.
  • Estimated aggregate market value of proposed sale: $5,746,846.04.
  • Shares acquired via stock option exercise on the same date (September 1, 2026).
  • Mottiwala previously sold 53,043 shares on August 19, 2026, and 81,332 shares on August 25, 2026.
  • Total insider sales by Mottiwala in the past two weeks exceed $15 million.
  • Market cap of TARS is ~$3.3B; proposed sale represents ~0.17% of market cap.

Financial Impact

Proposed sale of 77,698 shares valued at ~$5.75M; combined with recent sales totals ~$15.4M in two weeks.

insider holdingsfloat

Risk Factors

  • Continued insider selling could signal deteriorating confidence in the company's near-term prospects.
  • Large option-exercise sales may indicate the insider is monetizing equity ahead of a potential downturn.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-006607
Document: 0001959173-26-006607-index.html0001959173-26-006607
Document: 0001959173-26-006607.txt0001959173-26-006607

Track record

21 reports on TARS

Performance horizon

4 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +27.36% at T+20 after the Aug 6, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago 144 Neutral 2/10 Entry $76.56 Now $78.68 +2.78% settles Nov 23
  2. Nov 5, 202611d ago 3 Neutral 2/10 Entry $68.60 to $80.28 Now $78.68 +14.69% ▲ +17.03% +14.43% vs SPY
  3. Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $67.52 to $76.89 Now $78.68 +16.53% ▲ +13.88% +10.59% vs SPY
  4. Nov 3, 202613d ago 8-K Neutral 5/10 No price data
  5. Nov 3, 202613d ago Press Release Neutral 5/10 Entry $69.07 to $76.76 Now $78.68 +13.91% ▲ +11.13% +12.05% vs SPY
  6. Oct 16, 20264w ago Institutional Cluster Bullish 4/10 Entry $69.50 to $70.03 Now $78.68 +13.21% ▲ +0.76% +0.91% vs SPY
  7. Oct 13, 20264w ago S-3ASR Neutral 4/10 Entry $72.29 to $70.50 Now $78.68 +8.84% ▼ −2.48% −2.93% vs SPY
  8. Oct 13, 20264w ago S-3ASR Neutral 3/10 Entry $72.29 to $70.50 Now $78.68 +8.84% ▼ −2.48% −2.93% vs SPY
  9. Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $81.12 to $79.03 Now $78.68 −3.01% ▼ −2.58% −3.21% vs SPY
  10. Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $90.78 to $79.95 Now $78.68 −13.33% ▼ −11.93% −10.72% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 1, 2026